CO6341557A2 - Derivados nitrogenados de la pancratistatina - Google Patents

Derivados nitrogenados de la pancratistatina

Info

Publication number
CO6341557A2
CO6341557A2 CO11023614A CO11023614A CO6341557A2 CO 6341557 A2 CO6341557 A2 CO 6341557A2 CO 11023614 A CO11023614 A CO 11023614A CO 11023614 A CO11023614 A CO 11023614A CO 6341557 A2 CO6341557 A2 CO 6341557A2
Authority
CO
Colombia
Prior art keywords
pancratistatine
mixture
nitrogen derivatives
derivatives
narciclasin
Prior art date
Application number
CO11023614A
Other languages
English (en)
Inventor
Frederic Marion
Jean-Philippe Annereau
Jacques Fahy
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40394438&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6341557(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of CO6341557A2 publication Critical patent/CO6341557A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Abstract

Derivados nitrogenados de la narciclasina y de la pancratistatina, así como a su procedimiento de preparación y a su utilización en quimioterapia anticancerígena. Particularmente, un compuesto de fórmula general (I)o una sal farmacéuticamente aceptable del mismo, un isómero o una mezcla de isómeros en cualquier proporción, en particular una mezcla de enantiómeros, y en particular una mezcla racémica.
CO11023614A 2008-07-28 2011-02-25 Derivados nitrogenados de la pancratistatina CO6341557A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0855161A FR2934266B1 (fr) 2008-07-28 2008-07-28 Derives azotes de la pancratistatine

Publications (1)

Publication Number Publication Date
CO6341557A2 true CO6341557A2 (es) 2011-11-21

Family

ID=40394438

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11023614A CO6341557A2 (es) 2008-07-28 2011-02-25 Derivados nitrogenados de la pancratistatina

Country Status (24)

Country Link
US (2) US8415348B2 (es)
EP (1) EP2324031B1 (es)
JP (1) JP5666442B2 (es)
KR (1) KR20110036842A (es)
CN (1) CN102137867A (es)
AR (1) AR072880A1 (es)
AU (1) AU2009275929B2 (es)
BR (1) BRPI0916716A2 (es)
CA (1) CA2731901A1 (es)
CL (1) CL2011000168A1 (es)
CO (1) CO6341557A2 (es)
ES (1) ES2584165T3 (es)
FR (1) FR2934266B1 (es)
GE (1) GEP20135818B (es)
HU (1) HUE028098T2 (es)
IL (1) IL210868A0 (es)
MA (1) MA32588B1 (es)
MX (1) MX2011000956A (es)
NZ (1) NZ591298A (es)
PL (1) PL2324031T3 (es)
RU (1) RU2011106570A (es)
TW (1) TW201011031A (es)
WO (1) WO2010012714A1 (es)
ZA (1) ZA201101426B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010069054A1 (en) 2008-12-18 2010-06-24 Brock University Novel c-1analogs of pancratistatin and 7-deoxypancratistatin and processes for their preparation
CN101805384B (zh) * 2010-04-26 2014-08-20 江苏省中国科学院植物研究所 一种新石蒜异喹诺酮类生物碱及其制备方法和用途
GB2498539A (en) * 2012-01-18 2013-07-24 Renesas Mobile Corp Base station assisted asymmetric device-to-device communications
CN106543194A (zh) * 2015-09-22 2017-03-29 孙青* 水仙环素衍生物及其制备与在制备抗肿瘤药物中的应用
CN105481880B (zh) * 2015-12-01 2017-07-14 哈尔滨凝昇科技有限公司 一种新化合物及其应用
CN115677714A (zh) * 2022-11-01 2023-02-03 昆明医科大学 (+)-水鬼蕉碱制备中的中间体及其应用
CN115894507A (zh) * 2022-11-01 2023-04-04 昆明医科大学 (+)-水鬼蕉碱的合成方法及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4985436A (en) * 1984-02-17 1991-01-15 Arizona Board Of Regents Composition of matter for inhibiting leukemias and sarcomas
US5529989A (en) * 1995-01-09 1996-06-25 Arizona Board Of Regents Acting On Behalf Of Arizona State University Pancratistatin prodrug
DE60324196D1 (de) * 2002-12-09 2008-11-27 Univ Arizona Narcistatin-prodrugs
US7351830B2 (en) * 2003-06-20 2008-04-01 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University Pancratistatin cyclic phosphate prodrugs and phenpanstatin cyclic phosphate prodrugs
US20050261246A1 (en) 2004-03-05 2005-11-24 The Arizona Board Of Regents Methods for treating inflammatory and autoimmune diseases
CA2594569A1 (en) * 2005-01-14 2006-07-20 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Actin G For And On Behalf Of Arizona State University Synthesis of sodium narcistatin and related compounds
WO2008043846A2 (en) * 2006-10-13 2008-04-17 Unibioscreen Sa New isocarbostyril alkaloid derivatives having anti-proliferative and anti-migratory activities
WO2010069054A1 (en) * 2008-12-18 2010-06-24 Brock University Novel c-1analogs of pancratistatin and 7-deoxypancratistatin and processes for their preparation

Also Published As

Publication number Publication date
US20130121986A1 (en) 2013-05-16
CN102137867A (zh) 2011-07-27
ES2584165T3 (es) 2016-09-26
EP2324031A1 (en) 2011-05-25
IL210868A0 (en) 2011-04-28
JP2011529097A (ja) 2011-12-01
AU2009275929A1 (en) 2010-02-04
US8415348B2 (en) 2013-04-09
MA32588B1 (fr) 2011-08-01
CL2011000168A1 (es) 2011-07-15
RU2011106570A (ru) 2012-09-10
WO2010012714A1 (en) 2010-02-04
AR072880A1 (es) 2010-09-29
ZA201101426B (en) 2011-10-26
BRPI0916716A2 (pt) 2015-11-10
US8697064B2 (en) 2014-04-15
PL2324031T3 (pl) 2016-11-30
GEP20135818B (en) 2013-05-10
JP5666442B2 (ja) 2015-02-12
NZ591298A (en) 2011-12-22
TW201011031A (en) 2010-03-16
FR2934266A1 (fr) 2010-01-29
KR20110036842A (ko) 2011-04-11
US20110123516A1 (en) 2011-05-26
AU2009275929B2 (en) 2013-06-20
CA2731901A1 (en) 2010-02-04
HUE028098T2 (en) 2016-11-28
MX2011000956A (es) 2011-07-29
EP2324031B1 (en) 2016-05-04
FR2934266B1 (fr) 2010-09-17

Similar Documents

Publication Publication Date Title
CO6341557A2 (es) Derivados nitrogenados de la pancratistatina
CO6620055A2 (es) Ciertas amino-pirimidinas, composiciones de las mismas y métodos para el uso de los mismos
MX2012009186A (es) Pirrolidina-2-carboxamidas sustituidas.
MX2014014229A (es) Pirrolidina-2-carboxamidas sustituidas.
CO6630154A2 (es) Ciertas amino-piridazinas, composiciones de las mismas y métodos de uso de los mimos
RS54873B1 (sr) Policiklična-karbamoilpiridonska jedinjenja i njihova farmaceutska upotreba
ECSP12011799A (es) Compuestos de espiropiperidina y uso farmacéutico de los mismos
EA201200390A1 (ru) Макроциклические ингибиторы сериновых протеаз гепатита с
ECSP099436A (es) Acilaminopirazoles como inhibidores de fgfr
ECSP12012103A (es) Inhibidores de virus flaviviridae.
DE602007011902D1 (de) Spiroindolinon-derivate
ECSP11011258A (es) Pirimidinas fusionadas
MX2020005498A (es) Inhibidores de cdk.
CL2012000887A1 (es) Mezcla fungicida sinergica que comprende fluorocitosina y otros compuestos fungicos; composicion fungicida que comprende dicha mezcla y un adyuvante agricolamente aceptable o portador.
CL2016003301A1 (es) Compuestos derivados del ácido amino-(piridin-4-carboxílico) sustituidos, inhibidores de la histona desmetilasa; composición farmacéutica, que los comprende, útiles en el tratamiento del cáncer, tales como el cáncer de próstata, mama, vejiga, pulmón y/o melanoma.
CR20170159A (es) Nuevos compuestos tricíclicos
RS54123B1 (en) THERAPEUTIC COMBINATION CONTAINING DOLUTEGRAVIR, ABACAVIR AND LAMIVUDINE
DOP2013000142A (es) Derivados de biciclo[3,2,1]octilamida y sus usos.
UA111640C2 (uk) ПОХІДНІ [1,2,3]ТРИАЗОЛО[4,5-d]ПІРИМІДИНУ ЯК АГОНІСТИ КАНАБІНОЇДНОГО РЕЦЕПТОРА 2
TW200612958A (en) Substituted imidazole derivatives
UA113541C2 (xx) Заміщені піролідин-2-карбоксаміди
TN2015000084A1 (fr) Pyridinones bicycliques nouvelles
TW200800951A (en) Substituted imidazole compounds as KSP inhibitors
EA200900924A1 (ru) Циклизованные производные как ингибиторы eg-5
MX2014014832A (es) Pirrolopirimidona y pirrolopiridona, inhibidores de tanquirasa.

Legal Events

Date Code Title Description
FG Application granted